1. Socheongryongtang suppresses COPD-related changes in the pulmonary system through both cytokines and chemokines in a LPS COPD model
- Author
-
Chun-Sik Bae, Seung Sik Cho, Soon-Young Lee, Min-Suk Bae, and Dae-Hun Park
- Subjects
Lipopolysaccharides ,Chemokine ,traditional prescription ,Pharmaceutical Science ,Context (language use) ,RM1-950 ,ifn-γ ,030226 pharmacology & pharmacy ,01 natural sciences ,chronic obstructive pulmonary disease ,03 medical and health sciences ,Mice ,Pulmonary Disease, Chronic Obstructive ,0302 clinical medicine ,Drug Discovery ,Medicine ,Animals ,Medical prescription ,Lung ,Pharmacology ,COPD ,Mice, Inbred BALB C ,biology ,Dose-Response Relationship, Drug ,tnf-α ,Mechanism (biology) ,business.industry ,General Medicine ,medicine.disease ,Medicine, Korean Traditional ,0104 chemical sciences ,010404 medicinal & biomolecular chemistry ,Complementary and alternative medicine ,Immunology ,biology.protein ,Molecular Medicine ,Cytokines ,Female ,Plant Preparations ,Therapeutics. Pharmacology ,Chemokines ,business ,Research Article - Abstract
Context Socheongryongtang is a traditional Korean medical prescription used to treat pulmonary diseases. Objective This study investigated the therapeutic mechanism of socheongryongtang for pulmonary diseases. Materials and methods Seventy BALB/c mice were used: control, 0.8 mg/kg/study LPS intranasal instillation, 1 mg/kg/day Spiriva oral administration for five days, two socheongryongtang groups (150 or 1500 mg/kg/day orally treatment for five days). To illuminate the anti-COPD mechanism, several factors were evaluated such as WBC and differential counts in BALF and IgE in serum, morphological changes, and changes of COPD-related cytokines (TNF-α, IFN-γ, TGF-β) and chemokines (CXCL1, CCL-2, CCR2) in the lung. In order to confirm the statistical significance, all results were compared under p
- Published
- 2020